AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32362226 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 311
Study 34382217 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-testing
Number of subjects: 28
Study 34382217 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy
Number of subjects: 28
Study 32659637 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop
Number of subjects: 1173
Study 32659637 — intervention group
Group type: EXPERIMENTAL
Intervention: Apprenticeship
Number of subjects: 1173
Study 32659637 — intervention group
Group type: EXPERIMENTAL
Intervention: Consult
Number of subjects: 1173
Study 32659637 — intervention group
Group type: COMPARATOR
Intervention: Doing nothing
Number of subjects: 1173
Study 35078555 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT plus ESC
Number of subjects: 270
Study 35078555 — intervention group
Group type: COMPARATOR
Intervention: ESC alone
Number of subjects: 270
Study 34145486 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 12
Study 34145486 — intervention group
Group type: COMPARATOR
Intervention: SIT
Number of subjects: 12
Study 34145486 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT and SIT
Number of subjects: 12
Study 34083384 — intervention group
Group type: EXPERIMENTAL
Intervention: GPR84 and FFAR4 agonists
Number of subjects: 0
Study 34083384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33606782 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health measures (masking, physical distancing, contact tracing app, willingness to take a COVID-19 vaccine)
Number of subjects: 3000
Study 33606782 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health messaging
Number of subjects: 3000
Study 33606782 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 3000
Study 36344876 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Behavioral Parent Training (Helping the Noncompliant Child, HNC)
Number of subjects: 101
Study 36344876 — intervention group
Group type: COMPARATOR
Intervention: Technology-enhanced Behavioral Parent Training (TE-HNC)
Number of subjects: 101
Study 33405082 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG150 (150 mg/kg EGCG)
Number of subjects: 768
Study 36134437 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-treated phenylketonuria (ETPKU) group
Number of subjects: 40
Study 36134437 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals without PKU (control group)
Number of subjects: 40
Study 36134437 — intervention group
Group type: EXPERIMENTAL
Intervention: ETPKU group
Number of subjects: 40
Study 33797306 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction
Number of subjects: 86
Study 33797306 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral skills training
Number of subjects: 86
Study 33797306 — intervention group
Group type: COMPARATOR
Intervention: Waitlist period control
Number of subjects: 86
Study 35135585 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Arm Boot Camp (V-ABC) with feedback from a wearable device and 6 virtual sessions with a therapist
Number of subjects: 64
Study 35135585 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Arm Boot Camp (V-ABC)
Number of subjects: 64
Study 35135585 — intervention group
Group type: COMPARATOR
Intervention: Control group (3-week delayed entry)
Number of subjects: 64
Study 34340122 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% ?-mannanase enzyme in CSL diet
Number of subjects: 256
Study 34340122 — intervention group
Group type: COMPARATOR
Intervention: CSL diet without ?-mannanase enzyme
Number of subjects: 256
Study 34340122 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL with ?-mannanase enzyme
Number of subjects: 256
Study 34340122 — intervention group
Group type: EXPERIMENTAL
Intervention: ?‐mannanase enzyme
Number of subjects: 256
Study 34340122 — intervention group
Group type: COMPARATOR
Intervention: Control (CS) diet
Number of subjects: 256
Study 32160897 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling using the Skills Training Approach (STA)
Number of subjects: 68
Study 32160897 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 68
Study 35582122 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 1000
Study 35582122 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 1000
Study 33939887 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin and other polyphenol extracts (turmeric, red clover, flaxseed, resveratrol) at a dosage of 3 capsules/day (296.4 mg phenolics/capsule) for 5 ± 2 days before surgery
Number of subjects: 26
Study 33939887 — intervention group
Group type: COMPARATOR
Intervention: Control group (no capsules)
Number of subjects: 26
Study 34037693 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior Approach Hepatectomy
Number of subjects: 0
Study 34037693 — intervention group
Group type: COMPARATOR
Intervention: Conventional Hepatectomy
Number of subjects: 0
Study 35605174 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 1278
Study 35605174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1278
Study 33449603 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-stand desk
Number of subjects: 66
Study 33449603 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill desk
Number of subjects: 66
Study 33449603 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study 32755213 — intervention group
Group type: EXPERIMENTAL
Intervention: CT urography (CTU)
Number of subjects: 419
Study 34668323 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude
Number of subjects: 107
Study 34668323 — intervention group
Group type: EXPERIMENTAL
Intervention: Kindness
Number of subjects: 107
Study 34668323 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 107
Study 33761119 — intervention group
Group type: EXPERIMENTAL
Intervention: Fever prevention using the Arctic Sun System
Number of subjects: 1176
Study 33761119 — intervention group
Group type: COMPARATOR
Intervention: Standard temperature management (usual care)
Number of subjects: 1176
Study 32819312 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate-oriented tertiary interventions including assessments of folate status and metabolism, folate intake guidance, and re-evaluation of folate status to ensure red blood cell folate level above 400 ng/ml before pregnancy.
Number of subjects: 0
Study 32819312 — intervention group
Group type: COMPARATOR
Intervention: Routine perinatal care (control arm).
Number of subjects: 0
Study 32819312 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate-oriented tertiary interventions.
Number of subjects: 0
Study 35256203 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) on quadriceps muscles starting 1 day post LDLT for 4 weeks
Number of subjects: 40
Study 35256203 — intervention group
Group type: COMPARATOR
Intervention: Non-NMES (control) group
Number of subjects: 40
Study 33743290 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional intervention
Number of subjects: 1874
Study 33743290 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 1874
Study 33743290 — intervention group
Group type: EXPERIMENTAL
Intervention: NRS 2002 total score
Number of subjects: 1874
Study 36181548 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-urethral sling (MUS) surgery
Number of subjects: 5200
Study 34591584 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentoring + Mindfulness
Number of subjects: 35
Study 34591584 — intervention group
Group type: COMPARATOR
Intervention: Mentoring-as-usual
Number of subjects: 35
Study 33625291 — intervention group
Group type: EXPERIMENTAL
Intervention: Active air purifiers
Number of subjects: 127
Study 33625291 — intervention group
Group type: COMPARATOR
Intervention: Placebo air purifiers
Number of subjects: 127
Study 33571817 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of urinary cadmium concentration (median = 0.20; 25th, 75th = 0.13, 0.32 μg cadmium/g creatinine)
Number of subjects: 19394
Study 33571817 — intervention group
Group type: EXPERIMENTAL
Intervention: Per IQR increment in cadmium concentration
Number of subjects: 19394
Study 33571817 — intervention group
Group type: EXPERIMENTAL
Intervention: Using creatinine or osmolality to account for differences in urine dilution
Number of subjects: 19394
Study 32430769 — intervention group
Group type: EXPERIMENTAL
Intervention: Zero-profile device
Number of subjects: 41
Study 32430769 — intervention group
Group type: COMPARATOR
Intervention: Cage + plate
Number of subjects: 41
Study 34435371 — intervention group
Group type: COMPARATOR
Intervention: MK-8507 200 mg
Number of subjects: 18
Study 34435371 — intervention group
Group type: COMPARATOR
Intervention: MK-8507 800 mg
Number of subjects: 18
Study 34435371 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 18
Study 33606754 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided forearm nerve block
Number of subjects: 100
Study 33606754 — intervention group
Group type: COMPARATOR
Intervention: Forearm intravenous regional anaesthesia (IVRA)
Number of subjects: 100
Study 33044849 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent aerobic-resistance (A-R) training
Number of subjects: 51
Study 33044849 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent resistance-aerobic (R-A) training
Number of subjects: 51
Study 33044849 — intervention group
Group type: COMPARATOR
Intervention: Concurrent training (CT) (both A-R and R-A)
Number of subjects: 51
Study 34413391 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercise intervention for 16 weeks
Number of subjects: 49
Study 34413391 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 49
Study 32090730 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (100,000 IU per month for 24 months)
Number of subjects: 1615
Study 32090730 — intervention group
Group type: COMPARATOR
Intervention: No treatment (open practices)
Number of subjects: 1615
Study 32090730 — intervention group
Group type: COMPARATOR
Intervention: Placebo (double-blind practices)
Number of subjects: 1615
Study 32090730 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment or placebo)
Number of subjects: 1615
Study 35190446 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (Lorelco)
Number of subjects: 314
Study 35190446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study 34940862 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized sedation (intervention)
Number of subjects: 960
Study 34940862 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 960
Study 33401019 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nanoemulsion drops
Number of subjects: 99
Study 33401019 — intervention group
Group type: COMPARATOR
Intervention: Non-lipid-based aqueous drops
Number of subjects: 99
Study 34480522 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 171
Study 34480522 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 171
Study 34480522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 33785589 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to a pro bono lawyer
Number of subjects: 311
Study 33785589 — intervention group
Group type: COMPARATOR
Intervention: Minimal help (control group)
Number of subjects: 311
Study 33547808 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐PRF+IBB
Number of subjects: 62
Study 33547808 — intervention group
Group type: COMPARATOR
Intervention: CM+IBB
Number of subjects: 62
Study 32265255 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir (IDet) plus short acting insulin Novolin‐R before three meals (RRR‐IDet plan)
Number of subjects: 240
Study 32265255 — intervention group
Group type: COMPARATOR
Intervention: Neutral protamine Hagedorn (NPH) plus Novolin‐R before three meals (RRR‐NPH plan)
Number of subjects: 240
Study 35637412 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI plus cetuximab
Number of subjects: 0
Study 35637412 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI plus bevacizumab
Number of subjects: 0
Study 33340081 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT (Photobiomodulation therapy)
Number of subjects: 44
Study 33595486 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg/kg body weight) as an additive in peribulbar block
Number of subjects: 104
Study 33595486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 33595486 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 104
Study 32553818 — intervention group
Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS)
Number of subjects: 60
Study 32553818 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR/CT-derived sRV ejection fraction
Number of subjects: 60
Study 32553818 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of GLS and ejection fraction
Number of subjects: 60
Study 32553818 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical dispersion (MD)
Number of subjects: 60
Study 32553818 — intervention group
Group type: EXPERIMENTAL
Intervention: Postsystolic shortening (PSS)
Number of subjects: 60
Study 35881122 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept
Number of subjects: 118
Study 35881122 — intervention group
Group type: COMPARATOR
Intervention: Laser photocoagulation
Number of subjects: 118
Study 34293223 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporally intensified exposure (PeEx-I)
Number of subjects: 726
Study 34293223 — intervention group
Group type: COMPARATOR
Intervention: Standard nonintensified exposure (PeEx-S)
Number of subjects: 726
Study 32272516 — intervention group
Group type: EXPERIMENTAL
Intervention: HP/TAZ lotion (halobetasol propionate 0.01%/tazarotene 0.045%)
Number of subjects: 219
Study 32272516 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 219
Study 35268098 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrin DP 3
Number of subjects: 10
Study 35268098 — intervention group
Group type: COMPARATOR
Intervention: Dextrin DP 60
Number of subjects: 10
Study 35268098 — intervention group
Group type: COMPARATOR
Intervention: Dextran DP 60
Number of subjects: 10
Study 35268098 — intervention group
Group type: COMPARATOR
Intervention: Non-fully caloric Resistant Dextrin
Number of subjects: 10
Study 32677156 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous umbilical cord blood (UCB) stem‐cell therapy
Number of subjects: 8
Study 36455512 — intervention group
Group type: EXPERIMENTAL
Intervention: Values Affirmation Intervention + Fitspiration
Number of subjects: 238
Study 36455512 — intervention group
Group type: COMPARATOR
Intervention: Control Intervention + Fitspiration
Number of subjects: 238
Study 36455512 — intervention group
Group type: COMPARATOR
Intervention: Travel (control - viewed travel images only)
Number of subjects: 238
Study 34185582 — intervention group
Group type: EXPERIMENTAL
Intervention: FDM-informed manual therapy
Number of subjects: 33
Study 33196667 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis initiation
Number of subjects: 151
Study 35764923 — intervention group
Group type: EXPERIMENTAL
Intervention: GI_with (tool with integrated key questions)
Number of subjects: 126
Study 35764923 — intervention group
Group type: EXPERIMENTAL
Intervention: GI_without (tool without integrated key questions)
Number of subjects: 126
Study 35764923 — intervention group
Group type: COMPARATOR
Intervention: GC (control group, routine care)
Number of subjects: 126
Study 32157099 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise immediately before cognitive training
Number of subjects: 97
Study 32157099 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise immediately after cognitive training
Number of subjects: 97
Study 32157099 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise only
Number of subjects: 97
Study 32157099 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training only
Number of subjects: 97
Study 33438855 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938
Number of subjects: 32
Study 33438855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33919819 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-related harm prevention program (3 sessions)
Number of subjects: 45
Study 32472768 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal 'test and treat' (UTT) with annual population testing and universal ART
Number of subjects: 0
Study 32472768 — intervention group
Group type: COMPARATOR
Intervention: Baseline population testing with ART by country standard
Number of subjects: 0
Study 32472768 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal 'test and treat' (UTT)
Number of subjects: 0
Study 34155501 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with capecitabine (1,000 mg/m2 b.i.d for 14 days) and intravenous cisplatin (75 mg/m2 at day 1, every 3 weeks)
Number of subjects: 136
Study 34155501 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 136
Study 33661958 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body exercise (hybrid functional electrical stimulation rowing) performed 2-3 times per week for 30-60 minutes with a target heart rate of >75% of maximum.
Number of subjects: 61
Study 33661958 — intervention group
Group type: COMPARATOR
Intervention: Arms only exercise (upper body rowing exercise) performed with the same prescription as whole-body exercise.
Number of subjects: 61
Study 33661958 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (no explicit training regimen).
Number of subjects: 61
Study 33661958 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-hoc analysis for individuals with paraplegia.
Number of subjects: 61
Study 33007442 — intervention group
Group type: EXPERIMENTAL
Intervention: PCplanner intervention
Number of subjects: 2000000
Study 33007442 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2000000
Study 34564938 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg once daily for 180 days
Number of subjects: 312
Study 34564938 — intervention group
Group type: COMPARATOR
Intervention: No rosuvastatin for 6 months (Control)
Number of subjects: 312
Study 36268690 — intervention group
Group type: EXPERIMENTAL
Intervention: HFHD+HDF
Number of subjects: 0
Study 36268690 — intervention group
Group type: COMPARATOR
Intervention: LFHD+HDF
Number of subjects: 0
Study 33346320 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 20
Study 32029509 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m2 administered on days 1, 4, and 8 of each chemotherapy course.
Number of subjects: 1097
Study 32029509 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib with standard chemotherapy.
Number of subjects: 1097
Study 32029509 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy without bortezomib.
Number of subjects: 1097
Study 35654120 — intervention group
Group type: EXPERIMENTAL
Intervention: Coupled inhibitory‐facilitatory rTMS (1 Hz over contralesional M1 and 10 Hz over ipsilesional M1)
Number of subjects: 63
Study 35654120 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralesional sham stimulation and ipsilesional 10 Hz stimulation
Number of subjects: 63
Study 35654120 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralesional 1 Hz rTMS and ipsilesional sham stimulation
Number of subjects: 63
Study 35654120 — intervention group
Group type: COMPARATOR
Intervention: Bilateral sham stimulation only
Number of subjects: 63
Study 34762781 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 10
Study 34762781 — intervention group
Group type: COMPARATOR
Intervention: Thyroidectomy
Number of subjects: 10
Study 32557843 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking Safety (SS)
Number of subjects: 73
Study 32557843 — intervention group
Group type: COMPARATOR
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Number of subjects: 73
Study 32557843 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttreatment PTSD diagnosis
Number of subjects: 73
Study 32557843 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttreatment AUD diagnosis
Number of subjects: 73
Study 35738685 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive imagery condition
Number of subjects: 44
Study 35738685 — intervention group
Group type: COMPARATOR
Intervention: Neutral imagery condition
Number of subjects: 44
Study 32725589 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized embryo transfer (cET, n = 157 patients)
Number of subjects: 217
Study 32725589 — intervention group
Group type: COMPARATOR
Intervention: Control group (classical procedure, n = 60)
Number of subjects: 217
Study 35544456 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief befriending meditation
Number of subjects: 922
Study 35544456 — intervention group
Group type: COMPARATOR
Intervention: Attentional control condition
Number of subjects: 922
Study 32318834 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic transpapillary stent placement (ETSP)
Number of subjects: 12
Study 33739059 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Pharmacological Techniques (NPT) in addition to standard pharmacological techniques
Number of subjects: 50
Study 33739059 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacological techniques
Number of subjects: 50
Study 33020094 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy combined with medication (CBT+M)
Number of subjects: 0
Study 33020094 — intervention group
Group type: COMPARATOR
Intervention: Medication-only group (M)
Number of subjects: 0
Study 34365030 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Home Visiting (NHV)
Number of subjects: 722
Study 34365030 — intervention group
Group type: COMPARATOR
Intervention: Control: Universal well-child nursing service
Number of subjects: 722
Study 33172941 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous desmopressin 20 μg in 50 mL sodium chloride 0.9% infused over 20 min
Number of subjects: 50
Study 33172941 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 50